Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Cipla
Farmers Insurance
Julphar
Teva
US Department of Justice
Johnson and Johnson
Moodys
AstraZeneca

Generated: October 18, 2017

DrugPatentWatch Database Preview

Tranylcypromine sulfate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for tranylcypromine sulfate and what is the scope of tranylcypromine sulfate patent protection?

Tranylcypromine sulfate
is the generic ingredient in two branded drugs marketed by Par Pharm and Concordia Pharms Inc, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for tranylcypromine sulfate. Five suppliers are listed for this compound.

Summary for Generic Name: tranylcypromine sulfate

US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: see list6
Suppliers / Packagers: see list5
Clinical Trials: see list662
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:tranylcypromine sulfate at DailyMed

Pharmacology for Ingredient: tranylcypromine sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Concordia Pharms Inc
PARNATE
tranylcypromine sulfate
TABLET;ORAL012342-003Aug 16, 1985ABRXYesYes► Subscribe► Subscribe► Subscribe
Par Pharm
TRANYLCYPROMINE SULFATE
tranylcypromine sulfate
TABLET;ORAL040640-001Jun 29, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Citi
Teva
UBS
McKesson
Fuji
Julphar
QuintilesIMS
Boehringer Ingelheim
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot